Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kontigo Care ABFRA:3KT -2.10%32 EV-to-EBITDA is 8.02 as of Aug. 12, 2026, which is 34% below its 10-year median of 12.08. GuruFocus rates FRA:3KT with a GF Score™ of 32/100 and a GF Value™ of €0.09. The stock has 1 warning sign investors should review. Among 513 Healthcare Providers & Services companies, Kontigo Care AB ranks better than 50.68% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Kontigo Care AB's enterprise value is €3.30 Mil.
Kontigo Care AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €0.41 Mil. Therefore, Kontigo Care AB's EV-to-EBITDA for today is 8.02.
The historical rank and industry rank for Kontigo Care AB's EV-to-EBITDA or its related term are showing as below:
FRA:3KT'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -243.21 Med: 12.08 Max: 83.99
Current: 10.76
During the past 12 years, the highest EV-to-EBITDA of Kontigo Care AB was 83.99. The lowest was -243.21. And the median was 12.08.
FRA:3KT's EV-to-EBITDA is ranked better than 50.68% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.81
vs FRA:3KT: 10.76
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Kontigo Care AB (FRA:3KT) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Kontigo Care AB's PE Ratio (TTM) for today is calculated as:
Kontigo Care AB's share price for today is €0.084.
Kontigo Care AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Kontigo Care AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3KT vs VEEV, BTSG, HQY: EV-to-EBITDA Comparison
For the Health Information Services subindustry, Kontigo Care AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kontigo Care AB EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kontigo Care AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Kontigo Care AB's EV-to-EBITDA falls into.
Kontigo Care AB's current Enterprise Value is €3.30 Mil.
Kontigo Care AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kontigo Care AB (FRA:3KT) has a EV-to-EBITDA of 8.02 as of Aug. 12, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Kontigo Care AB. This is 34% below median its historical median of 12.08. According to the industry distribution chart, Kontigo Care AB ranks #253 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 49.3%.
Is Kontigo Care AB's EV-to-EBITDA too high?
Kontigo Care AB's current EV-to-EBITDA of 8.02 is 34% below median its 10-year median of 12.08. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.81. Kontigo Care AB's value of 8.02 is 25.8% below this industry median. Based on the distribution chart, Kontigo Care AB ranks #253 out of 513 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Kontigo Care AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Kontigo Care AB's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Kontigo Care AB ranks #253 out of 513 companies for EV-to-EBITDA. This puts Kontigo Care AB in the upper half of its industry. The industry median EV-to-EBITDA is 10.81. Kontigo Care AB's value of 8.02 is 25.8% below this benchmark. While the company's 10-year median is 12.08 vs. the industry median of 10.81, Kontigo Care AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.81, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kontigo Care AB's current EV-to-EBITDA of 8.02 is 25.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Kontigo Care AB. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kontigo Care AB's current EV-to-EBITDA is 8.02, which is 34% below median its own 10-year median of 12.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kontigo Care AB stock overvalued right now?
Kontigo Care AB (FRA:3KT) has a current EV-to-EBITDA of 8.02. The stock's GF Value™ is €0.09, compared to a current price of €0.08 — trading 6.7% below its estimated fair value. The current EV-to-EBITDA is 8.02, which is 34% below median its 10-year median of 12.08 and 25.8% below the Healthcare Providers & Services industry median of 10.81. Kontigo Care AB's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Kontigo Care AB (FRA:3KT), the current EV-to-EBITDA is 8.02 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kontigo Care AB (FRA:3KT) Overvalued in 2026?
Based on GuruFocus' analysis, Kontigo Care AB stock appears to be undervalued.
The current stock price of €0.08 is trading 6.7% below its estimated GF Value™ of €0.09.
Key valuation signals for FRA:3KT:
EV-to-EBITDA: 8.02 (34% below median its 10-year median of 12.08)
GF Value™: €0.09 vs. price of €0.08 (6.7% below fair value)
Industry Position: 25.8% below the Healthcare Providers & Services median (#253 of 513)
No single metric tells the full story. See the FRA:3KT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kontigo Care AB is a Sweden based company involved in offering a cloud-based platform with artificial intelligence (AI) and predictive capabilities. Its Kontigo Care platform has predictive capabilities, which means that a relapse can be identified early and, in some cases, completely prevented.
32GF Score
Get the complete analysis for FRA:3KT
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3KT has been successfully added to your 
